Literature DB >> 19175604

Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice.

K A Jackman1, A A Miller, T M De Silva, P J Crack, G R Drummond, C G Sobey.   

Abstract

BACKGROUND AND
PURPOSE: Reactive oxygen species (ROS) derived from Nox2-containing reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity is reportedly detrimental in cerebrovascular disease. However, ROS generation by other Nox isoforms may have a physiological role. No Nox2-selective inhibitors have yet been identified, and thus it is unclear whether isoform non-selective Nox inhibitors would necessarily improve outcome after stroke. We assessed the effect of apocynin on cerebrovascular ROS production and also on outcome following cerebral ischaemia when administered either before ischaemia or after cerebral reperfusion. The involvement of Nox2-containing NADPH oxidase in the effects of apocynin was assessed using Nox2(-/-) mice. EXPERIMENTAL APPROACH: Transient cerebral ischaemia was induced by 0.5 h middle cerebral artery occlusion followed by 23.5 h reperfusion. Mice received apocynin (2.5 mg.kg(-1), i.p.) either 0.5 h before ischaemia or 1 h after reperfusion. In situ superoxide production after cerebral ischaemia-reperfusion was measured in brain sections of wild-type mice at 24 h using dihydroethidium fluorescence. KEY
RESULTS: Treatment with apocynin 0.5 h before ischaemia reduced total infarct volume, neurological impairment and mortality in wild-type but not Nox2(-/-) mice. Conversely, treatment with apocynin 1 h after initiation of reperfusion had no protective effect. Cerebral ischaemia and reperfusion increased superoxide production in the brain at 24 h, and pretreatment but not posttreatment with apocynin reduced superoxide levels. CONCLUSIONS AND IMPLICATIONS: Apocynin improves outcome following stroke when administered before ischaemia in wild-type but not Nox2(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19175604      PMCID: PMC2697707          DOI: 10.1111/j.1476-5381.2008.00073.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  Novel NAD(P)H oxidases in the cardiovascular system.

Authors:  K K Griendling
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 2.  Vascular NADPH oxidases: molecular mechanisms of activation.

Authors:  Ralf P Brandes; Jörg Kreuzer
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

3.  NAD(P)H oxidases in rat basilar arterial endothelial cells.

Authors:  Tetsuro Ago; Takanari Kitazono; Junya Kuroda; Yasuhiro Kumai; Masahiro Kamouchi; Hiroaki Ooboshi; Masanori Wakisaka; Tsukasa Kawahara; Kazuhito Rokutan; Setsuro Ibayashi; Mitsuo Iida
Journal:  Stroke       Date:  2005-04-21       Impact factor: 7.914

4.  Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence.

Authors:  Hongtao Zhao; Joy Joseph; Henry M Fales; Edward A Sokoloski; Rodney L Levine; Jeannette Vasquez-Vivar; B Kalyanaraman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-11       Impact factor: 11.205

5.  Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils.

Authors:  J M Simons; B A Hart; T R Ip Vai Ching; H Van Dijk; R P Labadie
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

6.  Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo.

Authors:  Tamara M Paravicini; Sophocles Chrissobolis; Grant R Drummond; Christopher G Sobey
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914

7.  Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase.

Authors:  C E Walder; S P Green; W C Darbonne; J Mathias; J Rae; M C Dinauer; J T Curnutte; G R Thomas
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

8.  Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.

Authors:  C Iadecola; F Zhang; R Casey; M Nagayama; M E Ross
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

9.  NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium.

Authors:  K M Mohazzab; P M Kaminski; M S Wolin
Journal:  Am J Physiol       Date:  1994-06

10.  Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol.

Authors:  J Stolk; T J Hiltermann; J H Dijkman; A J Verhoeven
Journal:  Am J Respir Cell Mol Biol       Date:  1994-07       Impact factor: 6.914

View more
  66 in total

Review 1.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

Review 2.  Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.

Authors:  Jennifer Rivera; Christopher G Sobey; Anna K Walduck; Grant R Drummond
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

3.  Tat-NR2B9c prevents excitotoxic neuronal superoxide production.

Authors:  Yanting Chen; Angela M Brennan-Minnella; Sunil Sheth; Jamel El-Benna; Raymond A Swanson
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

4.  A combination antioxidant therapy to inhibit NOX2 and activate Nrf2 decreases secondary brain damage and improves functional recovery after traumatic brain injury.

Authors:  Raghavendar Chandran; TaeHee Kim; Suresh L Mehta; Eshwar Udho; Vishal Chanana; Pelin Cengiz; HwuiWon Kim; Chanul Kim; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-30       Impact factor: 6.200

Review 5.  Oestrogen signalling and neuroprotection in cerebral ischaemia.

Authors:  D Brann; L Raz; R Wang; R Vadlamudi; Q Zhang
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

6.  IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke.

Authors:  Shenpeng R Zhang; Marius Piepke; Hannah X Chu; Brad Rs Broughton; Raymond Shim; Connie Hy Wong; Seyoung Lee; Megan A Evans; Antony Vinh; Samy Sakkal; Thiruma V Arumugam; Tim Magnus; Samuel Huber; Mathias Gelderblom; Grant R Drummond; Christopher G Sobey; Hyun Ah Kim
Journal:  JCI Insight       Date:  2018-09-20

Review 7.  Vascular cognitive impairment and Alzheimer's disease: role of cerebral hypoperfusion and oxidative stress.

Authors:  Hyun Ah Kim; Alyson A Miller; Grant R Drummond; Amanda G Thrift; Thiruma V Arumugam; Thanh G Phan; Velandai K Srikanth; Christopher G Sobey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-08       Impact factor: 3.000

8.  Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus.

Authors:  Sapna Devi; Anqi Li; Clare L V Westhorpe; Camden Y Lo; Latasha D Abeynaike; Sarah L Snelgrove; Pam Hall; Joshua D Ooi; Christopher G Sobey; A Richard Kitching; Michael J Hickey
Journal:  Nat Med       Date:  2012-12-16       Impact factor: 53.440

9.  Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.

Authors:  Christoph Kleinschnitz; Henrike Grund; Kirstin Wingler; Melanie E Armitage; Emma Jones; Manish Mittal; David Barit; Tobias Schwarz; Christian Geis; Peter Kraft; Konstanze Barthel; Michael K Schuhmann; Alexander M Herrmann; Sven G Meuth; Guido Stoll; Sabine Meurer; Anja Schrewe; Lore Becker; Valérie Gailus-Durner; Helmut Fuchs; Thomas Klopstock; Martin Hrabé de Angelis; Karin Jandeleit-Dahm; Ajay M Shah; Norbert Weissmann; Harald H H W Schmidt
Journal:  PLoS Biol       Date:  2010-09-21       Impact factor: 8.029

10.  Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury.

Authors:  Kenji Dohi; Hirokazu Ohtaki; Tomoya Nakamachi; Sachiko Yofu; Kazue Satoh; Kazuyuki Miyamoto; Dandan Song; Shohko Tsunawaki; Seiji Shioda; Tohru Aruga
Journal:  J Neuroinflammation       Date:  2010-07-26       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.